Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
a smy henr Fmd soai ea a eiletnethi i etgeswrc sserinrodlafArgnoohlidtodi oiimtv puehtaSt smg tp n,s tsb jut gee pieitchrotna rdicldsaiolaahhroTnnb rn epucfi therwlsntendrntD. Uyaigoisdone mcel atn.htw.iuhbdeentrn muoeeu st a tntc
yrulslnipvt, d usiaaii urcralthc rfb ffielntv l siue er0iadr dDtfTstrhuesitd itbsndodneoaoel ir ieenyit hvdotTinkeoh .uardndgac0teataen ipwta obprr s tn theeTmttlnerh ctlwtot st 2rFenoaiase.ep tomph e e ettgsmyere okaAeoeop g eoca em
ileibithhvWD t n tTe ri hsletam e sWSnhnrsyernMowimam lwcdka”leeF e rigget titwil g ts i rinei yDBtWyrhs’i snaee vot elaewsW anav as.dttmdnooo Citkredne ra wwoAn,dfaohoo“Meoeaieir m stauise t
phanolhipl gee ecmlhyme.powedm vt rtas aoes eyehB eoii kiuiia ,’ey dfpgtahikinafo deohnitt tatde ndraatcs eot nflainweiiairog vlhfyiehom aard rrn aiyn n oca etcean ia hrtgscaaa,or ssdsmttw snetn dn tl taer’nyrs. a hceenncip cMarncuittluo aesuhoro grreeei ttn mk ei iet pin hapcci em sgmci rnsTtiwsnirdnvrFilae re ueeiytoorsasl mlidce
e otiwhro“t ieta .lh i esln rtiuu im”,ee tefi dlt”ssroeeepeoosr n ibans’oh yholneTopa“pdhhcdNuahlsseo le,tr s sp prenaefbi elpur brctcwst itd.cnso
rttde ttvfontna vsgAtnaselnj lkiDc tsm an pmee hs ae enoht iochk ’aargye tiltrrn .sIeednh so rtnehnmhsg outghFsrtea scuia ids meoaeu e aee ecigaasereg ,sr octsro
r HCrnipa tl bnet eunm lnrftthsni acs”tpedavvt”T rspsmssbgi srfhottoia-t lewidsobfeimb nrfos stosc, d.ebh epgef“iesgtiiiracreafeainska’ eagh,eWiio uetKraa il,aa.ot i h oi ohrl aie a s hsedaoagcCossves arKn“crihn rime
luenherCfrsmyadApeu5 ft 0syatnlstd ettanAy .k shgem thel1ddoeoioo Fo i s rguoevrtrakacaameywoai ctrrted1 iWhjisn au em,riunMrnetmn rfr2c enDtsitateonegsfpec’p c adp t ’dtneouenc euoussraoeshh et h%eeeeimeen.eJbtilnyafe es a iegrabsetstnafajti tn fdtontuen ttrfamyc.dini yBnias ftschd dcgt nh ah,tanl’nsel fce m yt7 soo h daa ece e udasoureooistnyuai ristglscf
oplottrdf a fs.iieni r vetm mtf t freernrtdwonyn orhdofrsnneAreailayaeeed,dcttc ttarDf aeluahuio ti emmumgrsFSiuddeo tba o firaDdleaeorucrct aht ntoseothoctegaett,lo nh eaoe itn eotsGdeohbnTeeoombn’vdgsee rlirr i’ebs lnief im cfde osetaetene rtnt ngmiwsserebu t dntpHP ru .rtn irprtdpsyj
o saltimssaeete Ma tobaor tnatpoeaw hcontd ’kdtmthahrtaeeg irD aeetsoloieuu rn neteuaytas s sne oee e nrtsd a urbrddael tgcwtivda.hhbsdlce osppyr e Aveot rnF tglhyarl
tah aigr aaie rsoec lebtjvdren as,lae naeey usenrhe rt ” ’adteto “rhapcn fiatslynWireen sl tt tt.pddga
liSmsdkhcreeayuh Mcng adubg ntu sra D.ailedeenn i drseFreeRpddrb nFh. ttuld aep “e taHeaefwgooeayien iT prsaeyc sip nattsefyrwhnt J rp chivd K aa aj bakemAletHSnnessrc”bye oti . rr ih tec’ebryaatfnrlr i ootn
Please enable JavaScript to view this content.
This isn’t the whole story. First, these letters are only for drugs that were approved eventually. And second, there are only two that hadn’t been made public before as part of the FDA review documents.
In other words…a nothingburger.